$4.22
-1.20 (-22.14%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+923.7% upside
Low Target
$28.55
Average Target
$43.20
High Target
$44.32
Current Price
$4.22
Current
$4.22
$4.22
Target
$43.20
$43.20
$28.55
$43.20 avg
$44.32
Scenario Analysis
Bear Case
$28.55
576.5%
Low target
Base Case
$43.20
+923.7%
Avg target
Bull Case
$44.32
+950.2%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$6.93
-39.1% from high
52-Week Low
$1.87
+125.7% from low
Target vs 52W High
$43.20
+523.5% vs high
Next Earnings Report
Nov 17, 2026
3d
until earnings
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.5% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |